Swedish Orphan Biovitrum AB has 3,021 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 5.1%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. We provide sustainable access to innovative therapies in the areas of haematology, immunology, and specialty indications. Today, we employ approximately 1,800 people across Europe, North America, the Middle East and Asia. In 2023, our revenue amounted to SEK 22.1 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at sobi.com.
As of September 2025
Swedish Orphan Biovitrum
workforce metrics
Headcount
3k
Avg. Salary
$132.9k
Tenure
3.8yr
Growth Rate
5.1%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Swedish Orphan Biovitrum annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Swedish Orphan Biovitrum annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?